JP
Jai Prakash Chaubey
About Jai Prakash Chaubey
Data last updated:
Jai Prakash Chaubey has 16 years in corporate governance. Holds Director role. Currently with 2 companies, including Sarva Pharmaceuticals Private Limited and Everest Pharmakon Private Limited. Engaged in General Business. Contributes to corporate operations. The largest current company by reported revenue is Sarva Pharmaceuticals Private Limited at ₹4.22 Cr (FY 2024).
Current companies
| Company | Designation | Appointment | Founded | Revenue | Status |
|---|---|---|---|---|---|
| Director | 24 Nov 2014 | 2014 | ₹4.22 Cr (FY 2024) | Active | |
| Director | 12 Nov 2009 | 2009 | – | Active |
Previous companies
Explore Director's current and past company associations Uncover their professional journey today!
Directorship timeline
Open interactive timeline →Shareholding and investment profile for Jai Prakash Chaubey
Company-level share counts, filed values, and quarterly changes require authenticated premium access.
- Company-level holdings
- Filed share counts
- Reported values
- Quarterly changes
Verified entity values are shown only after access is granted.
Frequently Asked Questions about Jai Prakash Chaubey
Jai Prakash Chaubey has 16 years in corporate governance. Holds Director role. Currently with 2 companies, including Sarva Pharmaceuticals Private Limited and Everest Pharmakon Private Limited. Engaged in General Business. Contributes to corporate operations. The largest current company by reported revenue is Sarva Pharmaceuticals Private Limited at ₹4.22 Cr (FY 2024).
Jai Prakash Chaubey is associated with 2 companies as Director, including Sarva Pharmaceuticals Private Limited (₹4.22 Cr), Everest Pharmakon Private Limited.
Jai Prakash Chaubey has expertise in General Business.
Jai Prakash Chaubey has 16 years in corporate governance.
By reported revenue, the largest current company of Jai Prakash Chaubey is Sarva Pharmaceuticals Private Limited, with revenue of ₹4.22 Cr (FY 2024).
Jai Prakash Chaubey currently holds positions at 2 companies: Sarva Pharmaceuticals Private Limited (₹4.22 Cr), Everest Pharmakon Private Limited.